Projects per year
Fingerprint
Dive into the research topics where Charles P France is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A novel opioid receptor antagonist for treating abuse and overdose
Project: Research project
-
-
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5/1/13 → 4/30/16
Project: Research project
-
-
Delay discounting: effects of drug dependence and withdrawal
7/15/10 → 6/30/16
Project: Research project
Research output
-
Countermeasures for Preventing and Treating Opioid Overdose
France, C. P., Ahern, G. P., Averick, S., Disney, A., Enright, H. A., Esmaeli-Azad, B., Federico, A., Gerak, L. R., Husbands, S. M., Kolber, B., Lau, E. Y., Lao, V., Maguire, D. R., Malfatti, M. A., Martinez, G., Mayer, B. P., Pravetoni, M., Sahibzada, N., Skolnick, P., Snyder, E. Y. & 3 others, , Mar 2021, In: Clinical Pharmacology and Therapeutics. 109, 3, p. 578-590 13 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone
Flynn, S. M. & France, C. P., Apr 1 2021, In: Drug and Alcohol Dependence. 221, 108599.Research output: Contribution to journal › Article › peer-review
-
Effects of remifentanil/histamine mixtures in rats responding under a choice procedure
Minervini, V., Tye, C. B., Ghodrati, S. & France, C. P., 2021, (Accepted/In press) In: Behavioural pharmacology. p. 278-285 8 p.Research output: Contribution to journal › Article › peer-review
-
Methocinnamox reverses and prevents fentanyl-induced ventilatory depression in rats
Jimenez, V. M., Castaneda, G. & France, C. P., Apr 1 2021, In: Journal of Pharmacology and Experimental Therapeutics. 377, 1, p. 29-38 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist
Mada, S., Gerak, L. R., Soyer, A., Maguire, D. R., Hu, Z., Minervini, V., Cunningham, C. W. & France, C. P., Dec 2020, In: Psychopharmacology. 237, 12, p. 3591-3602 12 p.Research output: Contribution to journal › Article › peer-review